Caenorhabditis elegans as a model for obesity research

被引:34
作者
Yue, Yiren [1 ]
Li, Sida [1 ]
Shen, Peiyi [1 ]
Park, Yeonhwa [1 ]
机构
[1] Univ Massachusetts, Dept Food Sci, Amherst, MA 01003 USA
基金
美国食品与农业研究所;
关键词
Caenorhabditis elegans; Fat metabolism; Obesity;
D O I
10.1016/j.crfs.2021.09.008
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Caenorhabditis elegans, a free-living nematode, is an animal model that has been extensively employed in a variety of research fields, including in the study of obesity. Its favorable features include its compact size, short life cycle, large brood size, easy handling, low cost, availability of complete genetic information, 65% conserved human diseases-associated genes, relatively easy genetic manipulation, and research using Caenorhabditis elegans does not require approvals by the Institutional Animal Care and Use Committee. These advantages make Caenorhabditis elegans a great in vivo model for life science research including obesity research. In this review, we provide graphic overviews of Caenorhabditis elegans' basic anatomy, growth conditions, routes of compound delivery, and fat metabolism, both synthesis and degradation pathways, including major signaling pathways involved. Our aim is to provide an overview for researchers interested in applying C. elegans as an in vivo model for the screening and identification of anti-obesity bioactive compounds prior to testing in vertebrate animal models.
引用
收藏
页码:692 / 697
页数:6
相关论文
共 24 条
[1]  
Altun Z.F., 2009, WORMATLAS, DOI [DOI 10.3908/WORMATLAS.1.4, 10.3908/wormatlas. 1.4]
[2]  
Avery Leon, 2012, WormBook, P1, DOI 10.1895/wormbook.1.150.1
[3]   Phenotypic Screening in C. elegansas a Tool for the Discovery of New Geroprotective Drugs [J].
Bulterijs, Sven ;
Braeckman, Bart P. .
PHARMACEUTICALS, 2020, 13 (08) :1-35
[4]   Delivery of dietary triglycerides to Caenorhabditis elegans using lipid nanoparticles: Nanoemulsion-based delivery systems [J].
Colmenares, Daniel ;
Sun, Quancai ;
Shen, Peiyi ;
Yue, Yiren ;
McClements, D. Julian ;
Park, Yeonhwa .
FOOD CHEMISTRY, 2016, 202 :451-457
[5]   Caenorhabditis elegans Show Preference for Stimulants and Potential as a Model Organism for Medications Screening [J].
Engleman, Eric A. ;
Steagall, Kevin B., II ;
Bredhold, Kristin E. ;
Breach, Michaela ;
Kline, Hannah L. ;
Bell, Richard L. ;
Katner, Simon N. ;
Neal-Beliveau, Bethany S. .
FRONTIERS IN PHYSIOLOGY, 2018, 9
[6]   Peroxisomal multifunctional enzyme type 2 from the fruitfly: dehydrogenase and hydratase act as separate entities, as revealed by structure and kinetics [J].
Haataja, Tatu J. K. ;
Koski, M. Kristian ;
Hiltunen, J. Kalervo ;
Glumoff, Tuomo .
BIOCHEMICAL JOURNAL, 2011, 435 :771-781
[7]   Dietary restriction of Caenorhabditis elegans by axenic culture reflects nutritional requirement for constituents provided by metabolically active microbes [J].
Lenaerts, Isabelle ;
Walker, Glenda A. ;
Van Hoorebeke, Luc ;
Gems, David ;
Vanfleteren, Jacques R. .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2008, 63 (03) :242-252
[8]   The Role of Nuclear Receptor NHR-64 in Fat Storage Regulation in Caenorhabditis elegans [J].
Liang, Bin ;
Ferguson, Kim ;
Kadyk, Lisa ;
Watts, Jennifer L. .
PLOS ONE, 2010, 5 (03)
[9]  
McGhee James D, 2007, WormBook, P1
[10]  
Page Antony P, 2007, WormBook, P1